These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11165970)

  • 1. Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
    Roguin A; Hochberg I; Nikolsky E; Markiewicz W; Meisel SR; Hir J; Grenadier E; Beyar R; Levy AP
    Am J Cardiol; 2001 Feb; 87(3):330-2, A9. PubMed ID: 11165970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation.
    Roguin A; Ribichini F; Ferrero V; Matullo G; Herer P; Wijns W; Levy AP
    Am J Cardiol; 2002 Apr; 89(7):806-10. PubMed ID: 11909563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.
    Roguin A; Koch W; Kastrati A; Aronson D; Schomig A; Levy AP
    Diabetes Care; 2003 Sep; 26(9):2628-31. PubMed ID: 12941730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: the Sleep Heart Health Study.
    Levy AP; Zhang L; Miller-Lotan R; Redline S; O'Connor GT; Quan SF; Resnick HE
    Sleep; 2005 Feb; 28(2):207-13. PubMed ID: 16171245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haptoglobin phenotype and vascular complications in patients with diabetes.
    Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
    N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty.
    Nye ER; Ablett MB; Robertson MC; Ilsley CD; Sutherland WH
    Aust N Z J Med; 1990 Aug; 20(4):549-52. PubMed ID: 2222347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflection point of ascending aortic waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty.
    Ueda H; Nakayama Y; Tsumura K; Yoshimaru K; Hayashi T; Yoshikawa J
    Am J Hypertens; 2002 Sep; 15(9):823-6. PubMed ID: 12219879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between the cholesteryl ester transfer protein gene--TaqIB polymorphism and coronary restenosis following percutaneous transluminal coronary angioplasty and stenting: a pilot study.
    Kaestner S; Patsouras N; Spathas DH; Flordellis CS; Manolis AS
    Angiology; 2010 May; 61(4):338-43. PubMed ID: 19815603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty.
    Carlsson J; Miketic S; Mueller KH; Brom J; Ross R; von Essen R; Tebbe U
    Lancet; 1997 Oct; 350(9086):1225. PubMed ID: 9652570
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty.
    Godfried SL; Deckelbaum LI
    Am Heart J; 1995 Jan; 129(1):203-10. PubMed ID: 7817919
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors for progression of atherosclerosis six months after balloon angioplasty of coronary stenosis.
    Benchimol D; Benchimol H; Bonnet J; Dartigues JF; Couffinhal T; Bricaud H
    Am J Cardiol; 1990 Apr; 65(15):980-5. PubMed ID: 2327359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restenosis after percutaneous transluminal coronary angioplasty.
    Pedersen HK; Vatne K; Simonsen S
    Acta Radiol; 1992 Mar; 33(2):149-51. PubMed ID: 1562409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the Watanabe heritable hyperlipidemic rabbit a suitable experimental model for percutaneous transluminal coronary angioplasty in humans? A light microscopic, immunohistochemical and ultrastructural study.
    Wanibuchi H; Dingemans KP; Becker AE; Ueda M; Naruko T; Tanizawa S; Nakamura K
    J Am Coll Cardiol; 1993 May; 21(6):1490-6. PubMed ID: 8473661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
    van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
    Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
    Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous transluminal coronary angioplasty in patients with spasm superimposed on atherosclerotic narrowing.
    Bertrand ME; Lablanche JM; Fourrier JL; Traisnel G
    Br Heart J; 1987 Nov; 58(5):469-72. PubMed ID: 2960366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients. Part 1: failure due to restenosis after simple PTCA].
    Warzée F; Legrand V; Scheen AJ
    Rev Med Liege; 2004 Oct; 59(10):584-90. PubMed ID: 15623079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.
    Levy AP; Hochberg I; Jablonski K; Resnick HE; Lee ET; Best L; Howard BV;
    J Am Coll Cardiol; 2002 Dec; 40(11):1984-90. PubMed ID: 12475459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.